Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2009;54:27-28
Published online before print June 1, 2009, doi: 10.1161/HYPERTENSIONAHA.109.131904
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
54/1/27    most recent
HYPERTENSIONAHA.109.131904v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Attramadal, H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Attramadal, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Obesity
Right arrow Peripheral vascular disease
Right arrow Clinical Studies
Right arrowRelated Article

(Hypertension. 2009;54:27.)
© 2009 American Heart Association, Inc.


Editorial Commentaries

Hypertension

Are We βARKing Up the Right Tree?

Håvard Attramadal

From the Institute for Surgical Research, Oslo University Hospital, Rikshospitalet and Center for Heart Failure Research, University of Oslo, Oslo, Norway.

Correspondence to Håvard Attramadal, Institute for Surgical Research, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, N-0027 Oslo, Norway. E-mail havard.attramadal@medisin.uio.no


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Hypertension is a common disorder with complex etiology and particularly high prevalence among black Americans. Although the pathophysiologic mechanisms of essential hypertension are poorly understood, the disease is often associated with increased sympathetic nervous activity and elevated plasma norepinephrine levels. Such elevated plasma norepinephrine levels may, in turn, lead to increased adrenergic receptor activities in the cardiovascular system. The significance of the elevated plasma norepinephrine levels in the pathophysiologic mechanisms leading to increased blood pressure is uncertain.

In the present issue of Hypertension, Cohn et al1 report the novel findings that G protein-coupled receptor kinase 2 (βARK1/GRK2) levels and activities correlate with both blood pressure and plasma norepinephrine levels in a cohort of black Americans with normal blood pressure or with essential hypertension and metabolic syndrome but without other known chronic disease. Although a minority of the patients in the cohort actually had hypertension according to the current clinical definition, the study convincingly demonstrates that GRK2 expression correlates with systolic blood pressure. No correlation with blood pressure was found for any of the other common members of the GRK family. It will be interesting to see in the future to what extent increased GRK2 activities pertain only to black Americans with essential hypertension or to what extent the reported findings are pathophysiological responses common to hypertension among all races.

GRKs are enzymes that catalyze phosphorylation and desensitization of agonist-activated G protein-coupled receptors, now preferably denoted as 7 transmembrane segment receptors. Thus, the authors contend that increased GRK2 levels cause . . . [Full Text of this Article]


Related Article:

G Protein–Coupled Receptor Kinase 2 Expression and Activity Are Associated With Blood Pressure in Black Americans
Heather I. Cohn, Yihuan Xi, Stephanie Pesant, David M. Harris, Terry Hyslop, Bonita Falkner, and Andrea D. Eckhart
Hypertension 2009 54: 71-76. [Abstract] [Full Text] [PDF]